Franklin India Technology Fund-Growth vs Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
Franklin India Technology Fund-Growth appears stronger based on its higher star rating of 5 compared to Tata India Pharma & Healthcare Fund-Direct Plan-Growth, which has a rating of 2. However, while Franklin's expense ratio is slightly higher at 1.16%, it has lower recent returns over the 1-year period at -5.8%, whereas Tata's fund has delivered positive returns of 6.66% in the same timeframe. Investors should note that while Franklin's fund may offer a better rating, Tata's fund has demonstrated superior returns over the short and long term, making it a potentially more attractive option despite its lower rating.
Franklin India Technology Fund-Growth
Franklin Templeton Mutual Fund
★★★★★
Equity · Sectoral
Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Tata Mutual Fund
★★★★★
Equity · Sectoral
| Metric | Franklin India Technol... | Tata India Pharma & He... |
|---|---|---|
| NAV | ₹544.36 | ₹38.7 |
| Star Rating | ★★★★★ | ★★ |
| Expense Ratio | 1.16% | 1.1% |
| AUM | ₹1,742 Cr | ₹1,511 Cr |
| 1M Return | +5.45% | +2.72% |
| 3M Return | -0.29% | -3.21% |
| 6M Return | +13.03% | +7.44% |
| 1Y Return | -5.8% | +6.66% |
| 3Y CAGR | +10.29% | +19.59% |
| 5Y CAGR | +7.22% | +15.19% |
| Risk Level | — | — |
| Fund Manager | Anand Radhakrishnan, Srikesh Nair, Varun Sharma | Rupesh Patel, Sonam Udasi |